Curative’s CEO said the company canceled a recurring $600,000 annual Salesforce bill after replacing the CRM with a new tool built with AI in two months. The update suggests cost reallocation and faster internal development, but provides no financial performance or guidance impact.
Curative’s CEO said the company canceled a recurring $600,000 annual Salesforce bill after replacing the CRM with a new tool built with AI in two months. The update suggests cost reallocation and faster internal development, but provides no financial performance or guidance impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
